Peer Review History

Original SubmissionOctober 19, 2022
Decision Letter - Mayank Gururani, Editor

PONE-D-22-28844Biochemical analysis, photosynthetic gene (psbA) down–regulation, and in silico receptor prediction in weeds in response to exogenous application of phenolic acids and their analogsPLOS ONE

Dear Dr. Ali,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 25 Dec. 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mayank Gururani

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“YES- Pakistan Science Foundation provided the resesrch funding through grant no. PSF-NSLP 663.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please respond by return e-mail so that we can amend your financial disclosure and competing interests on your behalf.

3. Thank you for stating the following in your Competing Interests section: 

“No authors have competing interests.”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

5. Please upload a copy of Figures S1 and S2, to which you refer in your text on page 13. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors studied the efficacy of the ferulic acid and gallic acid to three prevalent herbicide-resistant weed species. In silico analysis found new receptors of ferulic acid and gallic acid in psbA protein. They also found four analogs for developing plant based formulation to suppress weed growth. However, there several items shoul be addressed.

1. I can not read the supporting information.

2. Figure 9 B, it is strange to me that the effect of analog 1 is a, it seems similar with analog 6,7 and 11.

3. The effect of ferulic acid, gallic acid and the analogs to the germination of P. hysterophorus is missing.

4. Figure 8, There is no effect of of analog 1 to the germiantion of weed species. So, not four but three analogs have been identified.

Reviewer #2: In general the manuscript is sound and the data are well presented! Based on data presented the conclusions are well sustained! Hence, I recommend publication of the manuscript after a minor revision!

The choice of a semiquantitative PCR technique for determination of psbA transcripts is not ideal! A Real-time RT-PCR approach would have been more appropriate and is recommended. However if this is not possible please include in manuscript or supporting materials the quantitation of the reference gene. It is really important that the expression of this gene should not be influenced by your treatments.

The manuscript should also be carefully read for minor language and syntax errors!

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers

On behalf of all authors, I am highly thankful to the reviewers for their valuable time they have given to improve this manuscript. We have thoroughly reviewed the comments and improved the manuscript accordingly. Below are the reviewer’s comments (black marked) and responses to the comments (red marked)

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response 1. Manuscript has been checked thoroughly and we followed the journal format requirements.

2. Thank you for stating the following financial disclosure:

“YES- Pakistan Science Foundation provided the research funding through grant no. PSF-NSLP 663.”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please respond by return e-mail so that we can amend your financial disclosure and competing interests on your behalf.

Response 2. The mentioned statement about financial disclosure is correct and is also added in the manuscript. Please see page 24, line 513 – 516.

3. Thank you for stating the following in your Competing Interests section:

“No authors have competing interests.”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

This information should be included in your cover letter; we will change the online submission form on your behalf.

Response 3. "The authors have declared that no competing interests exist." also added in the main manuscript. Please see page 24, line 511.

4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

Response 4. Raw files of gel images and data are uploaded as supporting information. Captions for supporting information are added at the end of manuscript. Please see page 35, line 778 – 800.

5. Please upload a copy of Figures S1 and S2, to which you refer in your text on page 13. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

Response 5. Fig S1 – S4 are uploaded individually as supporting information. Captions for all supplementary figures are added. Please see page 35, line 778 – 800.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response 6. Needful done. Reference list has been reviewed thoroughly and it is according to the Journal guidelines. There are no retracted articles cited in the manuscript.

Reviewer #1: The authors studied the efficacy of the ferulic acid and gallic acid to three prevalent herbicide-resistant weed species. In silico analysis found new receptors of ferulic acid and gallic acid in psbA protein. They also found four analogs for developing plant based formulation to suppress weed growth. However, there several items should be addressed.

1. I cannot read the supporting information.

Response 1. Needful done. Supporting information including Fig S1 – S4 have been upload individually. Captions for all the supporting information are added at the end of the revised manuscript. Please see page 35, line 778 – 800.

2. Figure 9 B, it is strange to me that the effect of analog 1 is a, it seems similar with analog 6,7 and 11.

Response 2. The valuable comment is highly acknowledged. The figure has been rechecked and corrected. Please see updated Fig 9.

3. The effect of ferulic acid, gallic acid and the analogs to the germination of P. hysterophorus is missing.

Response 3. In vitro phytotoxicity of compounds was investigated against S. arvensis and L. multiflorum as representatives of dicot and monocot species. These two species grow easily and rapidly under similar in vitro conditions. [Please see:

• Javaid, M. M., Mahmood, A., Alshaya, D. S., AlKahtani, M. D., Waheed, H., Wasaya, A., ... & Fiaz, S. (2022). Influence of environmental factors on seed germination and seedling characteristics of perennial ryegrass (Lolium perenne L.). Scientific Reports, 12(1), 1-11.

• Singh, A., Mahajan, G., & Chauhan, B. S. (2022). Germination ecology of wild mustard (Sinapis arvensis) and its implications for weed management. Weed Science, 70(1), 103-111.]

In our earlier research it was observed that germination of S. arvensis and L. multiflorum took up to 3 and 5 days respectively while P. hysterophorus germinated between 10 to 15 days.

[Please see: Anwar, S., Naseem, S., Karimi, S., Asi, M. R., Akrem, A., & Ali, Z. (2021). Bioherbicidal Activity and Metabolic Profiling of Potent Allelopathic Plant Fractions Against Major Weeds of Wheat—Way Forward to Lower the Risk of Synthetic Herbicides. Frontiers in plant science, 333.]

Thus preliminary phytotoxicity and dose optimization of phenolic acids and analogs was performed against one dicot and monocot species each to determine their earlier responses for the purpose of standardization of experiments.

4. Figure 8, There is no effect of analog 1 to the germination of weed species. So, not four but three analogs have been identified.

Response 4. In principle we agree with this statement. Although analog 1 did not show significant inhibitory effect on the germination percentage but it was observed to have negative impact on seedling growth, since the seeds germinated, but could not grow well and wilted within the time of data collection. Statements have been amended as per suggestion by the worthy reviewer in the manuscript. Please see page 18, 19; line 378, 391 – 393. Further, biochemical analysis of investigated analogs against weeds also depicted negative results, including analog 1. Please see line 395 – 398.

Reviewer #2: In general, the manuscript is sound and the data are well presented! Based on data presented the conclusions are well sustained! Hence, I recommend publication of the manuscript after a minor revision!

The choice of a semiquantitative PCR technique for determination of psbA transcripts is not ideal! A Real-time RT-PCR approach would have been more appropriate and is recommended. However if this is not possible please include in manuscript or supporting materials the quantitation of the reference gene. It is really important that the expression of this gene should not be influenced by your treatments.

The manuscript should also be carefully read for minor language and syntax errors!

We appreciate the comment. Unfortunately, real-time PCR could not be performed, but the semi-quantitative PCR was performed with ultimate care and replicated to obtain valid results. Quantification of reference gene (tubulin) was done. Its expression was found to be uninfluenced by application of treatments, which can be been seen by the banding patterns and their quantification. The table for tubulin quantification along with the analysis of psbA gene is added as supporting information. Please see S1 Table. The manuscript has been carefully proofread for minor errors.

Attachments
Attachment
Submitted filename: Response to Reviewers (1).docx
Decision Letter - Mayank Gururani, Editor

Biochemical analysis, photosynthetic gene (psbA) down–regulation, and in silico receptor prediction in weeds in response to exogenous application of phenolic acids and their analogs

PONE-D-22-28844R1

Dear Dr. Ali,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mayank Gururani

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank you for considering my comments!

Given the authors response I consider the manuscript acceptable!

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Mayank Gururani, Editor

PONE-D-22-28844R1

Biochemical analysis, photosynthetic gene (psbA) down–regulation, and in silico receptor prediction in weeds in response to exogenous application of phenolic acids and their analogs

Dear Dr. Ali:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mayank Gururani

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .